DrugPatentWatch Database Preview

Litigation for OXYMORPHONE HYDROCHLORIDE

« Back to Dashboard

US Court Litigation for OXYMORPHONE HYDROCHLORIDE

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
7,276,250			2012-12-11		35:145 Civil Action to Obtain Patent	District Court, S.D. New York	None
7,276,250			2012-12-10		35:145 Civil Action to Obtain Patent	District Court, S.D. New York	None
7,276,250	Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc.		2013-05-15		35:145 Civil Action to Obtain Patent	District Court, S.D. New York	None
7,276,250	Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc.		2013-05-15		35:145 Civil Action to Obtain Patent	District Court, S.D. New York	None
7,276,250			2014-06-19		15:1 Antitrust Litigation	District Court, N.D. Illinois	Plaintiff
7,276,250			2014-07-16		15:1 Antitrust Litigation	District Court, N.D. Illinois	Plaintiff
7,276,250			2014-09-19		15:1 Antitrust Litigation	District Court, N.D. Illinois	Plaintiff

Patent Trial and Appeal Board Cases for OXYMORPHONE HYDROCHLORIDE

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
7,851,482			2013-12-19		Jen-Sen Dung et al	105			Jen-Sen Dung et al
7,851,482	Amneal Pharmaceuticals, LLC		2013-11-18	11-18-2013	Endo Pharmaceuticals Inc.	Inter partes review		06-03-2014	Jen-Sen Dung
8,309,122	Amneal Pharmaceuticals, LLC		2014-01-16	01-16-2014	Endo Pharmaceuticals, Inc.	Inter partes review		07-25-2014	Huai-Hung Kao
8,329,216	Amneal Pharmaceuticals, LLC		2014-01-16	01-16-2014	Endo Pharmaceuticals, Inc.	Inter partes review		07-25-2014	Haui-Hung Kao
8,329,216	Amneal Pharmaceuticals, LLC		2014-08-22	08-22-2014	Endo Pharmaceuticals, Inc.	Inter partes review		02-04-2015	Haui-Hung Kao